The knockdown of SNAP23 inhibited the tumorigenicity of CRC cells and significantly increased tolerance to OXA-based chemotherapy in nude mice (Fig. 2E–G and Supplementary Fig. S1E). This evidence concerns the gene SNAP23 and colorectal carcinoma.